Trademark Overview
On Tuesday, September 23, 2025, a trademark application was filed for GRAYBIO with the United States Patent and Trademark Office. The USPTO has given the GRAYBIO trademark a serial number of 99407720. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, February 13, 2026. This trademark is owned by Graybio, Inc.. The GRAYBIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations, namely radiotherapeutic preparations for use in oncological treatments and therapies; Drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of radiotherapeutics; Radiopharmaceutical compositions, namely, therapeutic radiopharmaceutical preparations for the treatment of cancer